Literature DB >> 19366616

Actin modulation of a MARCKS phosphorylation site located outside the effector domain.

Andrea Toledo1, Cristina Arruti.   

Abstract

MARCKS (Myristoylated alanine-rich C kinase substrate) is a ubiquitous actin regulating protein, especially abundant in the nervous system. This protein may be phosphorylated by other enzymes, particularly by proline-directed kinases, at serine and threonine residues located at different sites along its chain. We demonstrate here that the phosphorylation of chick MARCKS at serine 25, which only takes place in the nervous tissue, does not impair its association with particular plasma membrane regions such as the "detergent resistant microdomains" that also contain actin. This phosphorylated form of MARCKS is able to bind actin, and the integrity of actin filaments in cells (retina neuroblasts) is a necessary condition to sustain this phosphorylation. Taken together, these results indicate the existence of a functional interaction between actin filaments and MARCKS in cells, and particularly of an action in maintaining a phosphorylation in a region of the N-terminal moiety of MARCKS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19366616     DOI: 10.1016/j.bbrc.2009.04.029

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  A novel effect of MARCKS phosphorylation by activated PKC: the dephosphorylation of its serine 25 in chick neuroblasts.

Authors:  Andrea Toledo; Flavio R Zolessi; Cristina Arruti
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

2.  Searching for novel Cdk5 substrates in brain by comparative phosphoproteomics of wild type and Cdk5-/- mice.

Authors:  Erick Contreras-Vallejos; Elías Utreras; Daniel A Bórquez; Michaela Prochazkova; Anita Terse; Howard Jaffe; Andrea Toledo; Cristina Arruti; Harish C Pant; Ashok B Kulkarni; Christian González-Billault
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.